about
Germline mutations in BAP1 predispose to melanocytic tumorsMutations in GNA11 in uveal melanomaTwo-dimensional visualization of multicolor FISH-generated data as a helpful tool for the analysis and understanding of cytogenetic and chromosomal alterations in melanocytic lesions.Kinase fusions are frequent in Spitz tumours and spitzoid melanomas.Ambiguous melanocytic tumors with loss of 3p21.Clinical and pathologic findings of Spitz nevi and atypical Spitz tumors with ALK fusions.Therapy-induced tumour secretomes promote resistance and tumour progressionA distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression.Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathwayGNAQ and GNA11 mutations in melanocytomas of the central nervous systemTargeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathwayAlternative transcription initiation leads to expression of a novel ALK isoform in cancer.Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapyLoss of H3K27me3 Expression Is a Highly Sensitive Marker for Sporadic and Radiation-induced MPNST.NF1 Mutations Are Common in Desmoplastic Melanoma.Primary and Metastatic Cutaneous Melanomas Express ALK Through Alternative Transcriptional Initiation.Tumours associated with BAP1 mutations.Molecular biology methods to improve diagnosis and prognosis of melanocytic tumors.PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors.Spitz Tumors: Comparison of Histological Features in Relationship to Immunohistochemical Staining for ALK and NTRK1.Clinicopathologic and molecular features in cutaneous extranodal natural killer-/T-cell lymphoma, nasal type, with aggressive and indolent course.Investigation of Somatic GNAQ, GNA11, BAP1 and SF3B1 Mutations in Ophthalmic MelanocytomasLupus erythematosus with exclusive involvement of the acrosyringia.Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long-term follow up.BAP1 expression in cutaneous melanoma: a pilot study.Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas.Malignant dermatofibroma: clinicopathological, immunohistochemical, and molecular analysis of seven cases.A proposal for improving multicolor FISH sensitivity in the diagnosis of malignant melanoma using new combined criteria.Activating cysteinyl leukotriene receptor 2 (CYSLTR2) mutations in blue nevi.Combined BRAF(V600E)-positive melanocytic lesions with large epithelioid cells lacking BAP1 expression and conventional nevomelanocytes.Clinicopathologic features of early lesions of primary cutaneous follicle center lymphoma, diffuse type: implications for early diagnosis and treatment.Cutaneous lymphomas: from morphology to chip technology.Alterations of the cell-cycle inhibitors p27(KIP1) and p16(INK4a) are frequent in blastic plasmacytoid dendritic cell neoplasms.[Morphological and genetic aspects of Spitz tumors].Genomic Rearrangements in Unusual and Atypical Melanocytic Neoplasms.Absence of BRAF and HRAS mutations in eruptive Spitz naevi.Itch, skin lesions--and a stiff neck.Toward an Improved Definition of the Tumor Spectrum Associated WithBAP1Germline Mutations9p21 Deletion in Primary Cutaneous Large B-Cell Lymphoma, Leg Type, May Escape Detection by Standard FISH AssaysCutaneous Manifestations of Blastic Plasmacytoid Dendritic Cell Neoplasm—Morphologic and Phenotypic Variability in a Series of 33 Patients
P50
Q24594891-78E9CBCC-DF36-40A3-8EDA-4F0251B145B4Q24625723-8C4D3679-10D8-4E6A-9FE1-223BE58B63A1Q30609578-A0D9C325-8E02-4037-9234-232729E804A2Q33854847-382A4C71-FF85-4472-9DEF-321C488A154BQ33911349-F762B5A5-D9CF-481D-90CC-32CC8ADD7EFEQ34661027-BF7E78FC-AD54-42F8-ABEB-DCC67447557BQ35867131-C509E2EE-AC5C-4F63-A96B-BB61BDC62813Q35965678-77830851-007E-44AB-A98C-A055480DF3D3Q36109039-FA09AA4B-70B2-4FE7-A9DE-56A39C8F5BB0Q36391571-E2CEFC97-7356-469C-8205-6913AB4A2179Q36546559-52D11B04-F3F5-4E73-88AA-550B0D9447B7Q36726792-53977344-07BB-4E5F-8568-F23041F0E179Q36755569-87B4B84F-98AD-4D18-BCA9-F0A5A297C5EEQ36940306-BC7F8108-0504-4666-9622-8D117AFDB7D0Q37286915-7F853361-CC5F-4162-8273-B5E0D7759DCCQ37286919-97948DF6-C78C-4903-8052-B7F8A81DEC54Q38070634-4BE0BEFB-BBCA-4DE1-B267-316595FC6EAAQ38110625-F6F283C2-A1F7-4C88-BA96-CA25BB663AC2Q38954754-64A9F0FA-AC6E-4564-817B-21243E031B35Q40000142-4EE3E1EC-0CD5-4122-9A7F-99CAED3F4F5EQ42242860-82294CA3-CFDF-432A-8DDE-CD72816FB169Q42760068-0E85EBF1-FD5D-431C-9B04-33AF01E193A5Q43514297-4A479D6C-C5CF-45CE-B46B-C6D0566F913BQ44310776-DC26D95E-049C-4A4F-87B8-C77EC64C0685Q44663345-8A879920-A4F8-439F-9732-D51C8E374921Q45593807-1804A742-2AC7-4741-B938-B6E3B2955970Q45976170-D7B21483-EE92-43D8-90CD-E7609F0EA1C9Q47662455-994383F7-98D4-412D-9FB2-63C3DE766F4BQ50193210-25D1C973-897B-423E-B0F3-4CC5BD89764DQ51306849-F0CB87B3-8011-4A8F-A7F2-48EC22E15857Q51446114-24BBCBDC-A1A8-4981-955F-B4953DEE7F38Q51560700-B42E652F-F362-44F0-8C7A-88EB40A3422BQ53359204-B914713D-7774-4872-897E-F91DA5B8F478Q53637446-70542CB5-4267-4447-8169-43DC93488214Q54227804-A6887829-611E-47C5-8AF9-2D1577732201Q54603052-91F24946-12BC-4719-B013-54CD2EBC4F2FQ55467900-7075D31B-5589-45E5-BAB0-6D588273AC22Q57631287-4DE991E6-6E85-4CC6-9F8C-7DCCF8A947ADQ57631304-F04C9742-560C-4327-8B76-9311F7B98DCCQ59314783-06334D1D-57C9-4F61-95CC-B78F2B0E51AB
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Thomas Wiesner
@ast
Thomas Wiesner
@en
Thomas Wiesner
@es
Thomas Wiesner
@nl
Thomas Wiesner
@sl
type
label
Thomas Wiesner
@ast
Thomas Wiesner
@en
Thomas Wiesner
@es
Thomas Wiesner
@nl
Thomas Wiesner
@sl
prefLabel
Thomas Wiesner
@ast
Thomas Wiesner
@en
Thomas Wiesner
@es
Thomas Wiesner
@nl
Thomas Wiesner
@sl
P106
P21
P31
P496
0000-0001-5877-2992